These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15424449)

  • 21. The chemotherapy of rodent malaria. IX. Causal prophylaxis. I. A method for demonstrating drug action on exo-erythrocytic stages.
    Gregory KG; Peters W
    Ann Trop Med Parasitol; 1970 Mar; 64(1):15-24. PubMed ID: 5485706
    [No Abstract]   [Full Text] [Related]  

  • 22. Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses.
    White M; Amino R; Mueller I
    Trends Parasitol; 2017 Apr; 33(4):260-263. PubMed ID: 28077251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malaria vaccine: the effect of sporozoite-induced immunity on exo-erythrocytic stages.
    Bafort JM; Pryor WH; Beaudoin RL
    Ann Soc Belg Med Trop; 1978; 58(1):63-4. PubMed ID: 354537
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of dexamethasone and cyclophosphamide on development of exo-erythrocytic form of Plasmodium cynomolgi bastianellii in rhesus monkey].
    Hu YM; Nie M
    Zhongguo Yao Li Xue Bao; 1992 Sep; 13(5):478-80. PubMed ID: 1300058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [On the recently acquired knowledge of extra-erythrocytic forms of Plasmodium].
    PICK F
    Rev Coloniale Med Chir; 1949 May; 21(166):70-6. PubMed ID: 18127924
    [No Abstract]   [Full Text] [Related]  

  • 26. The chemotherapy of rodent malaria, XXXIV. Causal prophylaxis Part III: Ultrastructural changes induced in exo-erythrocytic schizonts of Plasmodium yoelii yoelii by primaquine.
    Boulard Y; Landau I; Miltgen F; Ellis DS; Peters W
    Ann Trop Med Parasitol; 1983 Dec; 77(6):555-68. PubMed ID: 6140901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell based assays for anti-Plasmodium activity evaluation.
    Mokgethi-Morule T; N'Da DD
    Eur J Pharm Sci; 2016 Mar; 84():26-36. PubMed ID: 26776968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The duration of Plasmodium falciparum infections.
    Ashley EA; White NJ
    Malar J; 2014 Dec; 13():500. PubMed ID: 25515943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase.
    Dutta S; Tewari A; Balaji C; Verma R; Moitra A; Yadav M; Agrawal P; Sahal D; Jarori GK
    Malar J; 2018 Aug; 17(1):304. PubMed ID: 30126436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro cultivation of Plasmodium falciparum. Applications and limits.- Methodology].
    Druilhe P; Gentilini M
    Med Trop (Mars); 1982; 42(4):437-62. PubMed ID: 6755144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Rheopathobiology of Plasmodium vivax and Other Important Primate Malaria Parasites.
    Russell BM; Cooke BM
    Trends Parasitol; 2017 Apr; 33(4):321-334. PubMed ID: 28040374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomics and epigenetics of sexual commitment in Plasmodium.
    Bechtsi DP; Waters AP
    Int J Parasitol; 2017 Jun; 47(7):425-434. PubMed ID: 28455236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MORPHOLOGY OF THE ERYTHROCYTIC STAGE OF PLASMODIUM INUI HALBERSTADTER AND PROWAZEK, 1907, IN THE TOQUE MONKEY, MACACA SINICA FROM CEYLON.
    JAYEWARDENE LG
    Indian J Malariol; 1963 Dec; 17():365-72. PubMed ID: 14296162
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pathogenic mechanisms in Plasmodium falciparum malaria].
    Vásquez AM; Tobón A
    Biomedica; 2012 Mar; 32 Suppl 1():106-20. PubMed ID: 23235819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development: bridging traditional mouse malaria models and human trials.
    Steel RW; Kappe SH; Sack BK
    Future Microbiol; 2016 Dec; 11(12):1563-1579. PubMed ID: 27855488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of pyrimethamine and sulphormethoxine on the pre-erythrocytic and sporogonous cycle of Plasmodium berghei berghei.
    Vincke IH
    Ann Soc Belges Med Trop Parasitol Mycol; 1970; 50(3):339-58. PubMed ID: 5514572
    [No Abstract]   [Full Text] [Related]  

  • 37. Evolutionary relationships of conserved cysteine-rich motifs in adhesive molecules of malaria parasites.
    Michon P; Stevens JR; Kaneko O; Adams JH
    Mol Biol Evol; 2002 Jul; 19(7):1128-42. PubMed ID: 12082132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADF2 is required for transformation of the ookinete and sporozoite in malaria parasite development.
    Doi Y; Shinzawa N; Fukumoto S; Okano H; Kanuka H
    Biochem Biophys Res Commun; 2010 Jul; 397(4):668-72. PubMed ID: 20529666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Autochthonous Plasmodium falciparum malaria and the malarial liver].
    Andrieu J; Doll J; Gardon JD
    Sem Hop; 1982 Sep; 58(32):1827-9. PubMed ID: 6291168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei.
    Milner EE; Berman J; Caridha D; Dickson SP; Hickman M; Lee PJ; Marcsisin SR; Read LT; Roncal N; Vesely BA; Xie LH; Zhang J; Zhang P; Li Q
    Malar J; 2016 Dec; 15(1):588. PubMed ID: 27923405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.